1. Academic Validation
  2. Antiproliferative Cardenolides from the Aerial Parts of Pergularia tomentosa

Antiproliferative Cardenolides from the Aerial Parts of Pergularia tomentosa

  • J Nat Prod. 2019 Jan 25;82(1):74-79. doi: 10.1021/acs.jnatprod.8b00630.
Seyed Hamzeh Hosseini 1 Milena Masullo 2 Antonietta Cerulli 2 Stefania Martucciello 3 Mahdi Ayyari 4 Cosimo Pizza 2 Sonia Piacente 2
Affiliations

Affiliations

  • 1 Department of Plant Biology , University of Jiroft , Jiroft , Iran.
  • 2 Dipartimento di Farmacia , Università degli Studi di Salerno , Via Giovanni Paolo II 132 , 84084 Fisciano , Salerno , Italy.
  • 3 Dipartimento di Chimica e Biologia , Università degli Studi di Salerno , Via Giovanni Paolo II 132 , 84084 Fisciano , Salerno , Italy.
  • 4 Department of Horticultural Science, Faculty of Agriculture , Tarbiat Modares University , Tehran , Iran.
Abstract

The LC-MS analysis of the MeOH extract of the aerial parts of Pergularia tomentosa led to the isolation of 23 compounds, of which the structures were elucidated unambiguously by NMR spectroscopic data analysis. Three new doubly linked cardenolides (4, 13, 14) along with several known cardenolides (1-3, 5, 7, 8, 15-23) and flavonol glycosides (6, 9-12) were identified. LC-HRESIMS analysis, in the negative-ionization mode, showed the absence of Flavonoids in a methanol extract of the roots of P. tomentosa. On the basis of the antiproliferative activity reported for cardenolides, the isolated compounds were tested for their ability to decrease the cell viability of five different human Cancer cell lines, PC3, HeLa, Calu-1, MCF-7, and U251MG, exhibiting IC50 values ranging from 0.2 to 8.0 μM. Moreover, an S-phase entry assay was performed to investigate if the compounds could affect the cell cycle progression of PC3 prostate carcinoma cells. The results obtained demonstrated that the compounds 4, 7, and 14 at 1 μM considerably reduced the number of cells in the S-phase.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-N1107
    Antiproliferative Activity